海外の治験の状況「1」での検索結果
2039件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- EE-ASI 1
- Type 1 diabetes MedDRA version: 18.1 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Sweden, United Kingdom
- 2015-12-04
Authorised
- Stratified Treatment OPtimisation for HCV-1 (STOPHCV-1)
- Hepatitis C Infection (HCV) (genotype 1a/1b/4) MedDRA version: 20.0 Level: PT Classification code 10008912 Term: Chronic hepatitis C System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- United Kingdom
- 2015-11-09
Authorised
- “ESTUDIO EN FASE IV de la Pauta de Rescate a través de OptimizacióN y simplificacióN de las dosis de Ritonavir en un régimen que contiene Tipranavir como parte del tratamiento” - Estudio PRONNTO
- Infección por VIH-1
- Spain
- 2007-02-20
Authorised
- TREATMENT OF HYPERPARATHYROIDISM IN PATIENTS WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 (MEN1) WITH THE CALCIMIMETIC AGENT CINACALCET - ND
- Primary hyperparathyroidism in patients affected with multiple endocrine neoplasia syndrome type 1 (MEN1) br>MedDRA version: 9.1 Level: LLT Classification code 10027180
- Italy
- 2010-03-11
Authorised
- Tendinopathy treatment effects and mechanisms 1 (TEAM 1):
- Achilles tendinopathy MedDRA version: 18.0 Level: LLT Classification code 10050471 Term: Achilles tendon pain System Organ Class: 100000004859 ;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
- United Kingdom
- 2015-08-06
Authorised
- Multi-center, open-label trial to evaluate the safety and tolerability of Alpha-1 MP in subjects with Alpha-1-antitrypsin (a1AT) deficiency. STAMP: Safety and Tolerability of Alpha-1 MP - STAMP
- Alpha-1 Antitrypsin (AAT) deficiency MedDRA version: 9 Level: LLT Classification code 10001806
- United Kingdom
- 2006-02-28
Authorised
- IMPACT D’UNE INTENSIFICATION THERAPEUTIQUE PAR INHIBITEUR D’INTEGRASE +/- INHIBITEUR DE CCR5 SUR LE RESERVOIR LYMPHOÏDE DU VIH-1 CHEZ DES PATIENTS AU STADE CHRONIQUE DE L’INFECTION - IntensVIH
- Infection à VIH-1
- France
- 2009-10-01
Authorised
- Adjusting antidepressant dosage according to the patient's ABCB1 genotype
- - Major Depression, single or recurrent, without psychotic features - Bipolar Disorders, currently depressed, without psychotic features MedDRA version: 14.1 Level: PT Classification code 10057840 Term: Major depression System Organ Class: 10037175 - Psychiatric disorders MedDRA version: 14.1 Level: PT Classification code 10004939 Term: Bipolar I disorder System Organ Class: 10037175 - Psychiatric disorders MedDRA version: 14.1 Level: PT Classification code 10004940 Term: Bipolar II disorder System Organ Class: 10037175 - Psychiatric disorders ;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
- Germany
- 2011-08-16
Authorised
- GLP-1 and hyperoxia for organ protection in heart surgery
- We investigate the efficacy of commercially available GLP-1 analog for reducing organ damage in patients undergoing heart surgery (i.e. coronary artery bypass grafting and/or aortic valve replacement). In addition we investigate the efficacy of restrictive versus liberal oxygenation (i.e. FiO2 50% versus FiO2 100%) for reducing organ damage during weaning after heart surgery. The study is a two-by-two factorial designed randomized clinical trial. MedDRA version: 20.0 Level: LLT Classification code 10008937 Term: Chronic ischemic heart disease, unspecified System Organ Class: 100000011627 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Denmark
- 2015-07-20
Authorised
- Frequency and mechanisms of resistance to IGF-1 generation in non-GH deficient short children with low IGF-1 concentration - IGF-1 generation protocol
- Prepubertal children with stature 1 MedDRA version: 9.1 Level: LLT Classification code 10040600 Term: Short stature
- Belgium
- 2009-05-12
